Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Lowy

Showing results (61-70 of 219) with videos related to

Pageof 22
Sort By:
Annals of Surgical Oncology|December 19, 2015
A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal ChemotherapyJoel M Baumgartner, Thomas G Kwong, Grace L Ma, et al.
Surgery|June 11, 2003
Osteoclast-like giant cell tumor of the pancreas associated with a mucinous cystadenocarcinomaAmod A Sarnaik, Aly G Saad, George K Mutema, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 25, 2010
Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancerRebecca J McClaine, Andrew M Lowy, Jeffrey J Sussman, et al.
Surgery|October 24, 2007
Fistulojejunostomy for the management of refractory pancreatic fistulaRajalakshmi R Nair, Andrew M Lowy, Benjamin McIntyre, et al.
Journal of the American College of Surgeons|September 14, 2022
Alvimopan for Enhanced Gastrointestinal Recovery after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Randomized Controlled TrialJoel M Baumgartner, Ruifeng Chen, Karen Messer, et al.
Annals of Surgical Oncology|August 9, 2020
Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal MetastasesJoel M Baumgartner, Paul Riviere, Richard B Lanman, et al.
Pancreas|May 8, 2013
A dual-color genetically engineered mouse model for multispectral imaging of the pancreatic microenvironmentCynthia S Snyder, Austin R Harrington, Sharmeela Kaushal, et al.
Radiology|July 25, 2023
Pancreatic Cyst Surveillance: Who, Why, How?Lyndon Luk, Andrew M Lowy, Kevin Li, et al.
Pancreas|June 16, 2012
Efficacy of dimethylaminoparthenolide and sulindac in combination with gemcitabine in a genetically engineered mouse model of pancreatic cancerMichele T Yip-Schneider, Huangbing Wu, Ralph H Hruban, et al.
Annals of Surgical Oncology|April 8, 2003
Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinomaAndrew M Lowy, Cecilia Fenoglio-Preiser, On Ja Kim, et al.
Pageof 22

Showing results (61-70 of 219) with videos related to

Sort By:
Pageof 22
Annals of Surgical Oncology|December 19, 2015
A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal ChemotherapyJoel M Baumgartner, Thomas G Kwong, Grace L Ma, et al.
Surgery|June 11, 2003
Osteoclast-like giant cell tumor of the pancreas associated with a mucinous cystadenocarcinomaAmod A Sarnaik, Aly G Saad, George K Mutema, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 25, 2010
Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancerRebecca J McClaine, Andrew M Lowy, Jeffrey J Sussman, et al.
Surgery|October 24, 2007
Fistulojejunostomy for the management of refractory pancreatic fistulaRajalakshmi R Nair, Andrew M Lowy, Benjamin McIntyre, et al.
Journal of the American College of Surgeons|September 14, 2022
Alvimopan for Enhanced Gastrointestinal Recovery after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Randomized Controlled TrialJoel M Baumgartner, Ruifeng Chen, Karen Messer, et al.
Annals of Surgical Oncology|August 9, 2020
Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal MetastasesJoel M Baumgartner, Paul Riviere, Richard B Lanman, et al.
Pancreas|May 8, 2013
A dual-color genetically engineered mouse model for multispectral imaging of the pancreatic microenvironmentCynthia S Snyder, Austin R Harrington, Sharmeela Kaushal, et al.
Radiology|July 25, 2023
Pancreatic Cyst Surveillance: Who, Why, How?Lyndon Luk, Andrew M Lowy, Kevin Li, et al.
Pancreas|June 16, 2012
Efficacy of dimethylaminoparthenolide and sulindac in combination with gemcitabine in a genetically engineered mouse model of pancreatic cancerMichele T Yip-Schneider, Huangbing Wu, Ralph H Hruban, et al.
Annals of Surgical Oncology|April 8, 2003
Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinomaAndrew M Lowy, Cecilia Fenoglio-Preiser, On Ja Kim, et al.
Pageof 22